Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
06/2005
06/08/2005EP1309575B1 Biphenyl derivatives and their use as ppar-gamma receptor activators
06/08/2005EP1259514B1 3-(pyrolyllactone)-2-indolinone compounds as kinase inhibitors
06/08/2005EP1252133B1 Pharmaceutical compounds
06/08/2005EP1251858B1 Podophyllotoxin compositions
06/08/2005EP1189895B1 Thiazole and oxazole derivatives and their pharmaceutical use
06/08/2005EP1176146B1 Carbamoyl tetrahydropyridine derivatives
06/08/2005EP1165031B1 Resorcinol composition
06/08/2005EP1102775B1 Novel phospholipids with unsaturated alkyl and acyl chains
06/08/2005EP1042305B1 INHIBITION OF p38 KINASE USING SYMMETRICAL AND UNSYMMETRICAL DIPHENYL UREAS
06/08/2005EP1024806B1 Use of non-immunosuppressive compounds for promoting nerve regeneration
06/08/2005EP1015459B1 Tetrazole-containing rapamycin analogs with shortened half-lives
06/08/2005EP0983304B1 Dermatan disulfate, an inhibitor of thrombin generation and complement activation
06/08/2005EP0849256B1 Amide compounds and use of the same
06/08/2005EP0793504B1 Chimeric cytokines and uses thereof
06/08/2005CN1625565A Antibodies to non-functional P2X7 receptor, diagnosis and treatment of cancers and other conditions
06/08/2005CN1625559A Novel compounds that inhibit factor Xa activity
06/08/2005CN1625558A Aza-arylpiperazines
06/08/2005CN1625557A Fluorenecarboxylic acid esters, process for the manufacture thereof, and use thereof as medicaments
06/08/2005CN1625554A Amides of aminoalkyl substituted azetidines, pyrrolidines, piperidines and azepanes
06/08/2005CN1625553A Treatment of male sexual dysfunction
06/08/2005CN1625549A Metabolites of (3-[[4-tert-butyl-benzyl)-(pyridine-3-sulfonyl)-amino]-methyl}-phenoxy)-acetic acid
06/08/2005CN1625411A Combination of a NSAID and a PDE-4 inhibitor
06/08/2005CN1625410A 2, 4, 6-triamino-1, 3, 5-triazine derivative
06/08/2005CN1625406A Formulation containing (lyso-) phosphatidylserine for the prevention and treatment of stress states in warm-blooded animals
06/08/2005CN1625405A Combinations comprising cox-2 inhibitors and aspirin
06/08/2005CN1625400A 2, 4-pyrimidinediamine compounds and their uses
06/08/2005CN1625397A Controlled release pharmaceutical dosage forms of a cholesteryl ester transfer protein inhibitor
06/08/2005CN1625390A Multi-stage oral drug controlled-release system
06/08/2005CN1625389A Method for making homogeneous spray-dried solid amorphous drug dispersions utilizing modified spray-drying apparatus
06/08/2005CN1625385A Lipase inhibiting composition
06/08/2005CN1623985A Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof
06/08/2005CN1623592A Preparation of preventing osteoporosis and delaying senility and its preparation process
06/08/2005CN1623434A Preparation method of lichee oral liquid containing intelligence beneficial component
06/08/2005CN1205226C Mouse interleukin-17 receptor sample protein, and coding gene and use thereof
06/08/2005CN1205220C Novel cyclosporins
06/08/2005CN1205210C 9-azabicyclo (3,3,1) non-2-ene and nonane derivatives as cholinergic ligands at nicotinic ACH receptors
06/08/2005CN1205207C Substituted indolealkanoic acids
06/08/2005CN1205205C Sodium-hydrogen exchanger type 1 inhibitor crystals
06/08/2005CN1205193C Crystalline form of 4-[5-methyl-3-phenylisoxazol)-4-yl] benzenesulfonamide
06/08/2005CN1205191C Novel acylguanidine derivatives as inhibitors of bone resorption and as vitronectin receptor antagonists
06/08/2005CN1205188C 4,5-dihydro-1h-pyrazole derivatives having CB1-antagonistic activity
06/08/2005CN1205187C New amidino derivatives and their use as thrombin inhibitors
06/08/2005CN1205186C ACE inhibitor nitric salts
06/08/2005CN1205183C New amidino derivatives and their use as thrombin inhibitors
06/08/2005CN1205181C Matrix metalloproteinase inhibitors
06/08/2005CN1204913C Medical wine for nourishing kidney and hair growing and its preparing process
06/08/2005CN1204889C Adhesion receptor antagonists
06/08/2005CN1204884C N-acetyl-L cysteine for preparing medicine for treating epithelial tumous
06/08/2005CN1204875C Delivery system for oral care compositions comprising organosiloxane resins using removable backing strip
06/08/2005CN1204870C Dental care compositions
06/07/2005US6903204 Polynucleotides encoding methionyl tRNA synthetase from Staphylococcus aureus, related products and methods
06/07/2005US6903203 Immunoglobulin for use in the diagnosis and therapy of cancer
06/07/2005US6903186 Analogues of GLP-1
06/07/2005US6903135 Methods and products related to 16-HETE analogs
06/07/2005US6903132 Non-peptide GnRH agents, pharmaceutical compositions and methods for their use
06/07/2005US6903131 Administering to a patient an antiangiogenesis or anticancer agent (N,N-disubstituted-3,4-diamino-2,4-dione-pyrroline derivatives for the treatment of chemokine-mediated diseases such as acute and chronic inflammatory disorders and cancer
06/07/2005US6903129 D-proline prodrugs
06/07/2005US6903121 Treatment of tumors with acetylenes disubstituted with a phenyl or heteroaromatic group and a substituted chromanyl, thiochromanyl or tetrahydroquinolinyl group in combination with other anti-tumor agents
06/07/2005US6903120 Modulators of dopamine neurotransmission
06/07/2005US6903115 Bipiperidine compounds
06/07/2005US6903112 Nitrogen compounds such as 1-benzenesulfonyl-3-piperidin-3-yl -1H-indole, used as serotonin receptor antagonists, for prophylaxis of nervous system disorders
06/07/2005US6903107 Serine protease inhibitor
06/07/2005US6903103 Linear cyclic ureas
06/07/2005US6903102 17β-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases
06/07/2005US6903098 Use of phthalazine derivatives
06/07/2005US6903096 Quinazoline derivatives as medicaments
06/07/2005US6903095 Phthalimido derivatives and a process for their preparation
06/07/2005US6903090 Such as 10-(2-ethoxyphenyl)-1,2,3,4,5,6-hexahydroazepino(4,5-b)indole; for treatment of anxiety, depression, schizophrenia, epilepsy, migraine, Alzheimers disease, sleep disorders, obesity, stress related diseases, and/or drug withdrawal
06/07/2005US6903089 Lactam-substituted pyrazolopyridine derivatives
06/07/2005US6903088 Compounds which inhibit leukocyte adhesion mediated by VLA-4
06/07/2005US6903087 Pyrido cyclohexenyl phenyl carboxamides tocolytic oxytocin receptor antagonists
06/07/2005US6903086 Alkoxycarbonylamino benzoic acid or alkoxycarbonylamino tetrazolyl phenyl derivatives as IP antagonists
06/07/2005US6903085 Substituted piperidine compounds useful as modulators of chemokine receptor activity
06/07/2005US6903082 Methods of treating inflammatory conditions of the gastrointestinal tract using 4-APAA and compositions thereof
06/07/2005US6903081 Phosphoramidates and methods therefor
06/07/2005US6903071 Cartilage/bone inducing materials for reparation
06/07/2005US6902908 Polypeptides, fusion proteins; includes production and use recombinant expression constructs having regulated promoter; mitochondria
06/07/2005US6902885 For detecting viral and cellular polypeptide interactions
06/07/2005US6902742 Pulsatile delivery of methylphenidate to treat attention deficit disorder
06/07/2005US6902739 Administering a stabilized rice bran derivative and a fortification agent; treating bone disorders
06/07/2005US6902734 Also an IL-12 anti-idiotype antibody to the antibody
06/07/2005US6902731 Transcription factors; for arterial administration via stent
06/07/2005CA2348026C Antibodies against semp1, methods for their production and uses thereof
06/07/2005CA2320180C Cyclohexanediole derivatives
06/07/2005CA2299036C 4-phenyl-4-heteroarylpiperidine derivatives
06/07/2005CA2281090C Sulfonamide compounds and salts for treatment of endothelin-mediated disorders
06/07/2005CA2209598C Aryl and heteroaryl purine compounds
06/07/2005CA2105529C Composition comprising non-steroidal anti-inflammatory agent and effectively non-antibacterial tetracycline
06/07/2005CA2074853C 2-aralkoxy and 2-alkoxy adenosine derivatives as coronary vasodilators and antihypertensive agents
06/07/2005CA2068790C Antiviral compounds
06/07/2005CA2051693C Allosteric hemoglobin modifiers
06/02/2005WO2005049834A1 Cell activator, hair growth stimulant and hair growth promoter
06/02/2005WO2005007845A3 Transgenic cells
06/02/2005WO2004112762A3 Pharmaceutical formulations of amyloid inhibiting compounds
06/02/2005US20050119499 Cyclic hemiacetal derivative and use thereof
06/02/2005US20050119492 Industrial scale acylation of 2-[1-(ethoxycarbonyl)butylamino]propionic acid with a carbonic acid derivative, activation with thionyl chloride, amidation with octahydroindol-2(S)-carboxylic acid, salt formation with tert-butylamine; hypotensive agents; angiotensin I-converting enzyme (ACE) inhibitor
06/02/2005US20050119489 Antidiabetic, anorexigenic, hypotensive, and anticholesterol agents that are synergistically combined with other active agents; obesity, premenstrual tension, hyperlipidemia, myocardial infarction and skin disorders
06/02/2005US20050119482 Hydroxynaphthyridinone carboxamides useful as hiv integrase inhibitors
06/02/2005US20050119345 2-Amino-3-alkoxy-6-fluorobicyclo[3.1.0]hexane-2,6-dicarboxylic acid derivatives; effective for treating and preventing psychiatric disorders such as schizophrenia, anxiety, bipolar disorder and epilepsy, neurological diseases such as drug dependence, Alzheimer's disease, Huntington's chorea
06/02/2005US20050119343 Crystalline form; inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase; for oral administration
1 ... 498 499 500 501 502 503 504 505 506 507 508 509 510 511 512 513 514 515 516 517 518 ... 1564